Bamlanivimab infusion experience at one academic emergency department

Am J Emerg Med. 2022 Jun:56:266-267. doi: 10.1016/j.ajem.2021.06.076. Epub 2021 Jul 12.

Authors

Michael J Yoo¹, Brit J Long², Steven G Schauer³

Affiliations

¹ Department of Emergency Medicine, Brooke Army Medical Center, Fort Sam Houston, TX, United States of America. Electronic address: michael.jay.yoo@gmail.com.
² Department of Emergency Medicine, Brooke Army Medical Center, Fort Sam Houston, TX, United States of America.
³ US Army Institute of Surgical Research, Fort Sam Houston, TX, United States of America.

No abstract available

Keywords: Bamlanivimab; COVID-19; Infusion; LY-CoV555; SARS-CoV-2.

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized* / therapeutic use
Antibodies, Neutralizing
Emergency Service, Hospital
Humans
SARS-CoV-2*

Substances

Antibodies, Monoclonal, Humanized
Antibodies, Neutralizing
bamlanivimab